VIGONVITA-B Shares Rise Over 5% Intraday as All Pre-IPO Investors Including Controlling Shareholder Voluntarily Extend Lock-Up Period

Stock News11-02

VIGONVITA-B (02630) shares rose more than 5% during intraday trading, up 3.45% as of press time to HK$78, with turnover of HK$12.3166 million.

On the news front, VIGONVITA-B issued an announcement stating that the company recently received notices from all pre-IPO investors, including the controlling shareholder, pursuant to which, based on their high recognition of the company's R&D pipeline value, the commercialization prospects of approved drugs, and the core management team, they have each committed that during the extended lock-up period lasting 7 months or 4 months from the expiry date of the original lock-up period, they will not reduce their respective shareholdings in the company in any manner.

The company believes that the extension of the lock-up period demonstrates the aforementioned shareholders' full confidence in the company's future prospects and long-term value.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment